These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Sonoda G; Palazzo J; du Manoir S; Godwin AK; Feder M; Yakushiji M; Testa JR Genes Chromosomes Cancer; 1997 Dec; 20(4):320-8. PubMed ID: 9408747 [TBL] [Abstract][Full Text] [Related]
23. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization. Parrella P; Caballero OL; Sidransky D; Merbs SL Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428 [TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. Sauter G; Moch H; Gasser TC; Mihatsch MJ; Waldman FM Cytometry; 1995 Sep; 21(1):40-6. PubMed ID: 8529469 [TBL] [Abstract][Full Text] [Related]
25. [Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer]. Oeggerli M; Schraml P; Novotny H; Sauter G; Simon R Verh Dtsch Ges Pathol; 2005; 89():219-24. PubMed ID: 18035695 [TBL] [Abstract][Full Text] [Related]
26. Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Richter J; Wagner U; Schraml P; Maurer R; Alund G; Knönagel H; Moch H; Mihatsch MJ; Gasser TC; Sauter G Cancer Res; 1999 Nov; 59(22):5687-91. PubMed ID: 10582685 [TBL] [Abstract][Full Text] [Related]
27. Molecular genetic alterations in superficial and locally advanced human bladder cancer. Presti JC; Reuter VE; Galan T; Fair WR; Cordon-Cardo C Cancer Res; 1991 Oct; 51(19):5405-9. PubMed ID: 1680549 [TBL] [Abstract][Full Text] [Related]
29. Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer. Yamamoto Y; Matsuyama H; Furuya T; Oga A; Yoshihiro S; Okuda M; Kawauchi S; Sasaki K; Naito K Clin Cancer Res; 2004 Oct; 10(19):6449-55. PubMed ID: 15475431 [TBL] [Abstract][Full Text] [Related]
30. Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines. Yang ZQ; Albertson D; Ethier SP Cancer Genet Cytogenet; 2004 Nov; 155(1):57-62. PubMed ID: 15527903 [TBL] [Abstract][Full Text] [Related]
31. Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC). Freier K; Schwaenen C; Sticht C; Flechtenmacher C; Mühling J; Hofele C; Radlwimmer B; Lichter P; Joos S Oral Oncol; 2007 Jan; 43(1):60-6. PubMed ID: 16807070 [TBL] [Abstract][Full Text] [Related]
32. Copy number gain at 8q12.1-q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas. Vékony H; Röser K; Löning T; Ylstra B; Meijer GA; van Wieringen WN; van de Wiel MA; Carvalho B; Kok K; Leemans CR; van der Waal I; Bloemena E Genes Chromosomes Cancer; 2009 Feb; 48(2):202-12. PubMed ID: 19009612 [TBL] [Abstract][Full Text] [Related]
33. Protein expression and gene copy number analysis of topoisomerase 2alpha, HER2 and P53 in minimally invasive urothelial carcinoma of the urinary bladder--a multitissue array study with prognostic implications. Krüger S; Lange I; Kausch I; Feller AC Anticancer Res; 2005; 25(1A):263-71. PubMed ID: 15816547 [TBL] [Abstract][Full Text] [Related]
34. Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH study. Placer J; Espinet B; Salido M; Solé F; Gelabert-Mas A Urology; 2005 May; 65(5):913-8. PubMed ID: 15882723 [TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of erbB-2 gene amplification in bladder cancer. Sauter G; Moch H; Moore D; Carroll P; Kerschmann R; Chew K; Mihatsch MJ; Gudat F; Waldman F Cancer Res; 1993 May; 53(10 Suppl):2199-203. PubMed ID: 8097962 [TBL] [Abstract][Full Text] [Related]
36. Tree models for dependent copy number changes in bladder cancer. Schäffer AA; Simon R; Desper R; Richter J; Sauter G Int J Oncol; 2001 Feb; 18(2):349-54. PubMed ID: 11172603 [TBL] [Abstract][Full Text] [Related]
37. Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma. Staebler A; Karberg B; Behm J; Kuhlmann P; Neubert U; Schmidt H; Korsching E; Bürger H; Lelle R; Kiesel L; Böcker W; Shih IeM; Buchweitz O Genes Chromosomes Cancer; 2006 Oct; 45(10):905-17. PubMed ID: 16845658 [TBL] [Abstract][Full Text] [Related]
38. Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer. Wagner U; Bubendorf L; Gasser TC; Moch H; Görög JP; Richter J; Mihatsch MJ; Waldman FM; Sauter G Am J Pathol; 1997 Sep; 151(3):753-9. PubMed ID: 9284824 [TBL] [Abstract][Full Text] [Related]
39. Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinoma. Sheu JJ; Lee CH; Ko JY; Tsao GS; Wu CC; Fang CY; Tsai FJ; Hua CH; Chen CL; Chen JY Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2709-16. PubMed ID: 19815638 [TBL] [Abstract][Full Text] [Related]